The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...
“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...
Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...
Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that ...
Today, the Colorectal Cancer Alliance’s Project Cure CRC announced new grants supporting 3 research projects at La Jolla Institute for Immunology, Virginia Tech, and the University of Arizona. 1 These ...
Total neoadjuvant treatment (TNT) may offer a promising alternative to surgery for patients with stage I rectal cancer (S1RC), a small study finds. 1 Among patients treated, TNT achieved a 93.7% ...
Many cancer types — breast, prostate, skin cancer — have 5-year survival rates and ample treatment options if caught early.
We reviewed all reports from the Jordan Cancer Registry over the past 20 years. Treatment outcome data were obtained from the King Hussein Cancer Center (KHCC) registry since its inception in 2006 ...
Colon cancer, also known as colorectal cancer, is one of the most frequent and aggressive cancers. According to the WHO, it ...
Medpage Today on MSN
Here's What's Driving Late Heart Events in Older Cancer Survivors
This study of older, long-term cancer survivors found that chemotherapy was not a driver of late cardiovascular disease (CVD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback